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Abstract
Background: Antibiotic over-prescribing has generally been considered to be common in Greece, however not
much is known about current antibiotic use.
Findings: The aim of this study was to investigate antibiotic prescribing in a well-defined rural population of 159
adults and 99 children over a 12-month period in Crete, Greece. The daily-defined doses (DDD) for 1000 people/
day (DID) were 22.1 and 24.2 for children and adults respectively. The overall DID was 23.4, markedly lower than
that previously reported for Greece. The use of penicillins was 49.5% of DDD in children and 31.7% in adults.
Quinolones represented 2.2% of the total antibiotics (0% in children). Prescriptions of antibiotics were more
common during the 3-month period from January to March for both children and adults.
Conclusions: The findings of this study confirm the seasonal distribution of antibiotics used and the
predominance of prescribing for respiratory tract infections. In the area of the study, antibiotic use seems to be
lower than that previously reported for Greece, probably as a result of the recently established net of well-trained
primary health physicians.
Background
Antibiotic prescribing in primary care rose steadily dur-
ing the last decade world-wide, in many European coun-
tries [1-7]. Unnecessary antibiotic prescribing remains
the cardinal contributing factor to the development of
antibiotic resistance [4,5,7,8]. Primary health care practi-
tioners have been shown to account for the majority of
antibiotic prescribing [3]. To prevent overprescribing,
detailed data on antibiotic utilization should be obtained
[9-11]. The use of markers such as the daily defined
doses of antibiotics (DDD), and the daily defined doses
for 1000 people/day (DID) for the estimation of antibio-
tic use has facilitated the comparison of the findings in
various countries [12]. Greece is among the European
countries with the highest antibiotic prescribing and
resistance to bacteria [3,4]. Information is very limited
for Crete, the major island of Greece [3,13-17]. The aim
of this study was to investigate antibiotic use in primary
health care in a region of Crete for a period of
12 months as well as to highlight the important role of
the family physicians.
Methods
The rural municipality of Gorgolaini, prefecture of Her-
aklion, Crete, has a population of 3026 (1543 male, 1483
female). Primary health services consist of two public
medical offices with 3 general practitioners. From an
initial sample of 2394 permanent residents, a representa-
tive cohort of 330 individuals was formed by the method
used for systematic samples of municipalities [18,19]. Of
them, 30 (9%) denied participation, and 42 (12.7%) were
not included due to lack of proper information on medi-
cal history and drug prescription. In total, 258 persons
participated in the study.
The collection of data for the 12-month period from
January 1 through December 31 was performed in
February and March of the following year (2005). Indivi-
dual health and prescription booklets were reviewed for
medical visits and prescriptions, and demographic and
insurance data were recorded. For each medical visit for
an infection, the prescribed medication and dosage of
the prescribed medication packages were recorded.
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peutic Chemical (ATC) classification system and the
doses according to the Defined Daily Dose (DDD) sys-
tem [12]. The diseases were coded according to the
World Health Organization-International Classification
of Diseases System (WHO-ICD 10). The statistical ana-
lysis was performed using the SPSS v.17.0. Chi-square
test was used in order to compare study variables. Sta-
tistical significance was accepted at the 5% level.
Ethics
The scientific committee of the Venizeleion Hospital of
Heraklion, Crete approved this study. All patients were
willing to participate in the study, and were informed
about the scope and the purpose of the study and gave
their consent.
Results
The age distribution of the population of the study was
as follows: male, age group 0-18: 21.7%, age group
19-65: 16.2%, age group 65+: 9.6%; and female age
group 0-18: 16.6%, age group 19-65: 21.3%, age group
65+ 14.6%. No significant difference was found between
males and females regarding age.
The distribution of diagnoses is depicted in Table 1.
Table 2 indicates the most frequently prescribed drugs,
in DDDs and DIDs. The DIDs for children were 22.1
and for adults were 24.2. The use of penicillins (J01C)
was 49.5% of DDDs in children and 31.7% in adults.
The most frequently prescribed antimicrobial drug was
amoxicillin-clavulanate (43.4% of the total DID in chil-
dren). The total percentage of cephalosporins (J01DA)
was 19.3% of DDDs in children and 29.7% in adults.
Ceplalosporins were the most frequently prescribed anti-
microbial agent in adults.
Macrolides represented 27.1% of the total DDD in
children, and 27.7% of DDD in adults. From the group
of macrolides-lincozamides (J01F) in children only clari-
thromycin was prescribed. In adults clarithromycin,
roxithromycin, telithromycin, azithromycin and clinda-
mycin represented 59%, 19%, 12%, 6%, and 4% respec-
tively of the total DDD of the J01F group. In children
penicillins were prescribed more often than in adults
(21.4% versus 39.1%, p = 0.049), but cephalosporins and
macrolides were prescribed less often compared to the
adults (30.7% versus 27.6% and 35.7% versus 27.6%,
respectively).
Antibiotic prescription according to infections is
depicted in Table 3. In respiratory diseases penicillins
(J01C) were prescribed in 48.9% and 33% of DDDs in
children and adults, respectively. In children penicillins
were prescribed for respiratory diseases in 48.9% of
D D Da n dw a st h em o s tc o m m o n l yp r e s c r i b e da g e n t ,
while cephalosporins were third in rank (20.1%). In
adults amoxicillin-clavulanate accounted for 20.7% and
cephalosporins for 30%. Macrolides for respiratory infec-
tions were commonly prescribed (29% and 37% for
Table 1 Most common diagnoses in adults and children
in the study
Infection Episodes %
Children Respiratory 72 82.8
Skin-soft tissues 7 8
Tooth abscess 5 5.7
Gastrointestinal 2 2.3
Others 1 1.1
Adults Respiratory 100 71.4
Skin-soft tissues 16 11.4
Urinary 12 8.6
Tooth abscess 8 5.7
Genital 4 2.9
Table 2 Prescribed antibiotics as DDD and DID, and
percentages
Effective Substance Frequency DDD DID % DDD
Children
Penicillins J01C
￿ Phenoxymethyl-penicillin
J01CE02
1 6 0.17 0.8
￿ Amoxicillin J01CA04 5 42 1.16 5.3
￿ Amoxicillin-clavulanate
J01CR02
28 346 9.57 43.4
Cephalosporins J01DA 24 154 4.26 19.3
Macrolides J01F 24 216 5.98 27.1
Sulphonamides QJ01EQ 1 14.4 0.4 1.8
Antifungals D01 2 10.5 0.29 1.3
Antiviral J05A 1 2.5 0.07 0.3
Antiprotozoal-anthelminthics (P01-
P02)
1 6 0.17 0.8
Total 87 797 22.1
Adults
Penicillins J01C
￿ Phenoxymethyl-penicillin
J01CE02
2 12 0.21 0.9
￿ Amoxicillin J01CA04 12 162 2.79 11.5
￿ Amoxicilline-clavunalate
J01CR02
16 272 4.68 19.3
Cephalosporins J01DA 43 418 7.2 29.7
Macrolides J01F 50 389 6.7 27.7
Quinolones J01M 5 55 0.95 3.9
Imidazoles J01XD 2 15 0.26 1.1
Sulphonamides QJ01EQ 3 30 0.52 2.1
Lincozamides J01F 2 8 0.14 0.6
Antifungals D01 5 46 0.79 3.3
Total 140 1407 24.2
DDD = daily defined doses of antibiotics, DID = daily defined doses of
antibiotics for 1000 people/day.
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prescribed in 2.2% of the total antibiotics, but were the
most common agent in adult urinary tract infections
(41.4% of the total DDD). Chi-square test showed no
differences in (DID) and number of visits between male
and female as well as between adults and children
(r>0,05). In both children and adults, antibiotics were
more commonly prescribed during January-February-
March (39.6% and 32.2% of the total year, for children
and adults respectively), followed by the last quarter
(24.2% and 26.3% respectively).
Discussion
In the present study DIDs were lower than that pre-
viously recorded for Greece [3]. This could be
explained in part by the fact that in the previous dec-
ade family practice in rural areas has been provided by
uncertified physicians. Further in urban areas there
isn’t an established net of well-trained primary health
physicians. Over the last decade family practice has
reached a revolution and general practitioners provide
primary health care services in rural areas as in our
study. Our findings further confirmed the seasonal
fluctuation of prescriptions, the increased use of broad
spectrum antibiotics and the predominance of pre-
scriptions for respiratory tract infections (82.8% and
the 71.4% in children and adults, respectively). This is
in accordance with Goosens et al study that included
32 countries [3]. In adult respiratory infections, peni-
cillins, cephalosporins and macrolides-lincozamides
shared almost equal amounts of the total DDDs. In
contrast, in children penicillins were more commonly
prescribed. Macrolides-lincozamides accounted for 48%
for respiratory infections in adults and 31.9% in chil-
dren, considerably higher than the percentages (18%)
reported previously for Greece [20].
The overall DID rate was 23.4. This DID is one of the
h i g h e s ta m o n gE u r o p e a nC o u n t r i e s ,b u ti ts h o u l db e
stressed that it is lower than the proportions given by
the ESAC Project Group for Greece [3]. Recently, rural
areas in Greece are increasingly being served by physi-
cians specialized in general practice and this may have
contributed to more rational antibiotics prescribing.
The assumption although of DDD and DID in chil-
dren has several limitation problems as DDDs are nor-
mally assigned based on use in adults. The Guidelines
for ATC classification and DDD assignment [21] state
that the medication dose recommendations will be dif-
ferent depending on the age and body weight of the
patient. Because of this, the WHO International Work-
ing Group for Drug Statistics Methodology has deter-
mined that it is impossible to assign pediatric DDDs,
and studies that attempt to investigate drug utilization
in children cannot use them. They further recommend
that the general DDD be used as a measuring instru-
ment for overall comparisons when the pediatric sub-
group is difficult to identify. Therefore in our study the
expression of the prescribing DDD in children might
have as a result a misserpretation as it relates to an
average adult weight. It can be concluded that medica-
tion use is considered greater than that estimated, as we
cannot estimate precisely DDD and DID in children
Table 3 DDDs, DIDs and percentages of DDD of antibiotics according to infection
Infection Antimicrobial agents % children % adults DDD children (%) DDD adults (%) DID children DID adults
Respiratory Penicillins J01C 37.5% 22% 344 (48.9%) 337.5 (33%) 9.53 9.67
Cephalosporins J01DA 29.2% 30% 142 (20.1%) 306 (30%) 3.92 5.27
Macrolides, lincozamides J01F 31.9% 48% 204 (29%) 378 (37%) 5.65 6.51
Sulphonamides J01E 1.4% 0 14.4 (2%) 0 0.4 0
Urinary Penicillins J01C 8.3% 24 (18%) 0.41
Cephalosporins J01DA 25% 24 (18%) 0.41
Quinolones J01M 41.7% 55 (41.4%) 0.95
Sulphonamides J01 25% 30 (22.6%) 0.52
Skin-soft tissues Penicillins J01C 42.8% 6.3% 15.4 (52.4%) 12 (8.3%) 0.58 0.21
Cephalosporins J01DA 28.6% 62.5% 6.5 (19.5%) 88 (60%) 0.18 1.52
Macrolides, lincozamides J01F 12.5% 11 (7.5%) 0.19
Other 28.6% 18.7% 7.5 (25.5%) 35.5 (24.2%) 0.21 1.09
Genital Other 100% 25.5 (100%) 0.57
Gastrointestinal Macrolides, lincozamides J01F 50% 12 (66.7%) 0.33
Other 50% 6 (33.3%) 0.17
Tooth abscess Penicillins J01C 80% 75% 30 (83.3%) 72 (90%) 0.83 1.86
Cephalosporins J01DA 20% 6 (16.7%) 0.17
Macrolides, lincozamides J01F 25% 8.0 (10%) 0.14
Various Other 100% 2.5 (100%) 0.07
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for a drug in adults). As our results showed no signifi-
cant differences between adults and children it could be
estimated that in children either there was a higher
morbidity or there was an overuse of antibiotics. It
probably means that much bigger fractions of children
compared to adults were treated with antibiotics. Even
although with these limitations on DDD and DID use,
an overall estimation of antibiotic prescribing can be
concluded.
The use of penicillins in children was satisfactory
(49.5% of DIDs) but not in adults (31.7%). The overall
use of penicillins in our study (38.1 of DDD) was higher
than what was previously reported for Greece (31.1%
and 21%) by Tzimis et al [14] and Molstad et al [4]
respectively. In accordance with previous studies [3-5],
the use of phenoxymethylpenicillin accounted for 1.5%
of the total DDD of penicillins in children and 2.7% in
adults. The increased use of wide-spectrum penicillins
and particularly of amoxicillin-clavulanate has been also
observed in the adjacent rural Anogia Health Centre
area [13]. The predominance of broad spectrum agents
has been noted in many countries and has been attribu-
ted to marketing campaigns, making physicians less sen-
sitive to cost and quality of the prescribed drugs, and
the belief that respiratory infections are an indication
for antimicrobials [22-24]. All prescribed cephalosporins
were of the second generation. No first-generation
cephalosporins were prescribed, again a finding suggest-
ing the unjustified overuse of broad-spectrum agents
even in simple infections. No third generation cephalos-
porins were prescribed, mainly due to the stringent
instructions for cephalosporin use that has been
imposed by the Greek ministry of health since 1997.
T h eo b s e r v e di n c r e a s ei nt h eu s eo fm a c r o l i d e sm a yb e
explained by the availability of newer agents. Macrolides
accounted for 32.6% of the total prescriptions, a percen-
tage that was higher in comparison with other studies
such as Molstad et al and Tzimis et al studies (21.9% of
the total prescriptions and 22.5% of DDDs, respectively)
[4,14]. Macrolides were also used very frequently in the
Anogeia Health Centre area, a neighboring county of
Crete [13].
The previous prescribed overuse of second generation
cephalosporines and macrolides is a well known problem
worldwide that leads to a Streptococcus pneumoniae resis-
tance resulting in serious not easily treated infections [25].
Use of non recommended, more expensive, broader-
spectrum antibiotics is frequent also in other studies [26].
There is growing concern that using second generation
cephalosporins and macrolides may lead common patho-
gens to develop antibiotic resistance to Streptococcus
pneumoniae, Steptococcus pyogenes and Haemophilus
influenzae [3,25,27]. Further antimicrobial resistance of
S. pneumoniae to penicillin at a country level is often due
to macrolides and beta-lactam antibiotics [28]. A systema-
tic review and meta-analysis on the effect of antibiotic pre-
scribing in primary care on antimicrobial resistance
showed that individuals that were prescribed an antibiotic
in primary care for a respiratory or urinary infection devel-
oped bacterial resistance to that antibiotic [29]. This
increases the bacterial resistance to first line antibiotics,
and has as a result an increased use of second line antibio-
tics in the community [29].
Although quinolones can be prescribed in Greece only
under specific indications, their use was not rare in our
study (2.2% of the total antibiotics), mainly for adult
urinary tract infections, where quinolones held first
position (42%). Interestingly not a single prescription of
quinolones was documented in children. Comparing our
findings with those previously reported for Greece [20],
a fall in the percentage of sulfonamides and an increase
of quinolones was observed.
In our study there was no registration of antiprotozoal
medications and only one registration of a vermifuge
medicine. This finding, compatible with a previously
report for Crete [30], reflects the optimal hygiene level
of the area. Regarding the seasonal distribution of the
medical visits, the majority of the antibiotics were pre-
scribed during the first quarter of the year. In Goosens
et al study [3] the seasonal distribution in 32 European
countries had a mean increase ≥30% in Southeastern
countries in the first and last quarter of the year, while
the mean increase in North countries was less than 25%.
The decrease of DDD, the lack of third generation
cephalosporins prescriptions, and the lack of quinolones
prescribed in children are indications that proper medical
education and restrictions of prescriptions can help to
improve antibiotic utilization in countries with high anti-
biotic use. On the other hand, the increase of prescribed
broad-spectrum agents such as second-generation cepha-
losporins and quinolones stress that much more must
be done.
Further this study showed that the primary indication
for antibiotic prescribing was respiratory infections, both
in adults and children. In Gjelstad et al study in Norway
the respiratory infections accounted for the 60% of gen-
eral practitioners’ antibiotic prescriptions [31]. Findings
were similar in our study. In the Gjelstad et al study the
antibiotic prescription has been shown to be influenced
by various factors including type of infection, type of
contact, being a general practitioner specialist, and years
since medical exam [31]. In a retrospective cohort study
that took place in UK, adults had higher probability of
receiving an antibacterial prescription for a respiratory
infection visit compared to children [32]. The antibac-
terial prescribing declined faster for younger patients
than for adults after the implication of successful UK
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cines. Over the last several years a decline in antibiotics
prescription in children has been reported in England
[33] and this has been attributed to the significant reduc-
tion in GPs prescriptions. In our study a high antibiotic
prescription for respiratory infections in children has
been found, showing that further effort is needed to
change GPs approach to childhood respiratory infections.
Implications to the Greek health care system
Today, Greece spends almost 9.7% of the GDP (Gross
Domestic Product) for health expenses and there is
much of discussion about the present economical state,
and the medication cost in Greece as well as in Europe.
Our study findings should be of interest to health policy
makers who are in an extremely difficult financial situa-
tion at this time, which should generate more attention
to the general practitioner/family medicine specialty that
now represents only the 2% of doctors.
Strengths and limitations
This study has some limitations which should be
reported. The study is a prevalence study so it does not
give information about its change overtime. It is a small
sample study so broad conclusions cannot be drawn.
Large multicenter studies are needed in order to elimi-
nate local factors that can influence the results. The
study was conducted in only two rural areas of Crete,
and therefore could not be representative of every
G r e e kr u r a lc o m m u n i t y ,s ot h ef i n d i n g so ft h i ss t u d y
could not be generalized for the whole Greek popula-
tion. The use of over the counter medicines can not be
excluded. The fact that we used a retrospective analysis
of antibiotics in patients without interview may have as
result an underestimation of the total antibiotic use.
Further the attempted comparison between adult and
pediatric antibiotic use has several limitations as co-
morbidity factors were not examined (diabetes, asthma
etc) as well as a possibility of misestimating the results
as DDDs are not recommended for children. On the
other hand this is a real life study and it is among the
few published regarding antibiotic use in primary health
care in rural areas in Greece.
Conclusions
In conclusion, although our findings were derived from
a rather limited rural population, it suggests that well
trained, primary health physicians rationally distribute
antibiotics in the community setting. The findings of
this study confirm the seasonal distribution of antibio-
tics use and the predominance of prescribing for
respiratory tract infection. The overuse of cephalospor-
ines and macrolides as revealed in our study represent a
major issue for the public health as it could be asso-
ciated with increased antibiotic resistance.
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